ALok Tripathi

Dr. ALok Tripathi


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 February 2024 in Discover Nano
Verified
Journal Article
Open access
PDF file
MYMohammad Yasir
Mohammad Yasir
RMRatnakar Mishra
Ratnakar Mishra
ATALok Tripathi
ALok Tripathi
RMRahul K. Maurya
Rahul K. Maurya
ASAshutosh Shahi
Ashutosh Shahi
VMVijay Hariram Masand
Vijay Hariram Masand
Biomaterials play a vital role in targeting therapeutics. Over the years, several biomaterials have gained wide attention in the treatment and diagnosis of diseases. Scientists are trying to make more personalized treatments for different diseases, as well as discovering novel single agents that can be used for prognosis, medication administration, and keeping track of how a treatment works. Theranostics based on nano-biomaterials have higher sensitivity and specificity for disease management than conventional techniques. This review provides a concise overview of various biomaterials, including carbon-based materials like fullerenes, graphene, carbon nanotubes (CNTs), and carbon nanofibers, and their involvement in theranostics of different diseases. In addition, the involvement of imaging techniques for theranostics applications was overviewed. Theranostics is an emerging strategy that has great potential for enhancing the accuracy and efficacy of medicinal interventions. Despite the presence of obstacles such as disease heterogeneity, toxicity, reproducibility, uniformity, upscaling production, and regulatory hurdles, the field of medical research and development has great promise due to its ability to provide patients with personalised care, facilitate early identification, and enable focused treatment.

1 January 2024 in BIO Integration
Verified
Journal Article
Open access
PDF file
JTJyoti Trivedi
Jyoti Trivedi
MYMohammad Yasir
Mohammad Yasir
RMRahul Maurya
Rahul Maurya
ATALok Tripathi
ALok Tripathi
Cancer remains a major global health burden, necessitating innovative approaches for improved diagnosis and treatment. Aptamer-based theranostics have gained attention in the field of cancer research and treatment. Aptamers can be used as targeting ligands for the delivery of therapeutic agents to cancer cells, as well as for the detection and imaging of cancer, due to high binding affinity and selectivity. Aptamers are also being investigated as anticancer drugs. Specifically, aptamers serve as a tool for controlling protein activity via protein-protein and protein-ligand interactions. The aptamer-exosome technology improves aptamer targeting. To gather relevant data, we searched scientific databases, including PubMed/Medline, Google Scholar, Wiley, Web of Science, and Springer. Despite challenges, theranostics, environmental monitoring, biosensing, and other fields could benefit from the use of aptamer technology. This review discusses the standard methods for producing aptamers, including green aptamers, and potential applications in diagnostics. Aptamers are useful in biotherapy and as anticancer drugs, and this article gives a thorough overview of both with examples. We also covered aptamer-exosome technologies, aptasensors, and their diagnostic and therapeutic applications. We investigated recent systematic evolution of ligands by exponential enrichment (SELEX) methodologies with a focus on carrier materials and technical advances, and discuss the difficulties in creating aptamers that are more practical, highly efficient, and stable.

13 April 2024 in Journal of Biochemical and Molecular Toxicology
Verified
Journal Article
Closed access
SGShweta Subhash Giri
Shweta Subhash Giri
ATALok Tripathi
ALok Tripathi
PEPınar Erkekoğlu
Pınar Erkekoğlu
MZMagdi E. A. Zaki
Magdi E. A. Zaki

1 July 2013 in Saudi Pharmaceutical Journal
Verified
Journal Article
Open access
ATALok Tripathi
ALok Tripathi
ISI. Sheikh
I. Sheikh
ADA.P. Dewani
A.P. Dewani
PSP.G. Shelke
P.G. Shelke
RBR.L. Bakal
R.L. Bakal
PMP.M. Mazumder
P.M. Mazumder
Sildenafil citrate (SIL) is used in the treatment of erectile dysfunction and other chronic disorders. For the pharmacokinetic investigation of SIL we developed a simple and sensitive method for the estimation of SIL in rat plasma by reverse phase high-performance liquid chromatography (RP-HPLC). The drug samples were extracted by liquid-liquid extraction with 300 μl of acetonitrile and 5 ml of diethyl ether. Chromatographic separation was achieved on C18 column using methanol:water (85:15 v/v) as mobile phase at a flow rate of 1 ml/min and UV detection at 230 nm. The retention time of SIL was found to be 4.0 min having a separation time less than 5 min. The developed method was validated for accuracy, precision, linearity and recovery. Linearity studies were found to be acceptable over the range of 0.1-6 μg/ml. The method was successfully applied for the analysis of rat plasma sample for the application in pharmacokinetic study, drug interaction, bioavailability and bioequivalence.

5 April 2024 in Life Sciences
Verified
Journal Article
Closed access
SCShushmita Chand
Shushmita Chand
ATALok Tripathi
ALok Tripathi
ADAnil P. Dewani
Anil P. Dewani
NSNaheed Waseem A. Sheikh
Naheed Waseem A. Sheikh

18 October 2010 in Tropical Journal of Pharmaceutical Research
Verified
Journal Article
Open access
PDF file
ATALok Tripathi
ALok Tripathi
VCV Chitra
V Chitra
NSNaheed Waseem A. Sheikh
Naheed Waseem A. Sheikh
DMD.S Mohale
D.S Mohale
ADA.P Dewan
A.P Dewan
Immunomodulatory Activity of the Methanol Extract of Amorphophallus campanulatus (Araceae) Tuber